⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL284532 | 1.00 | — | — | |
| SCHEMBL408223 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL11798083 | 0.97 | — | — | |
| SCHEMBL642579 | 0.88 | — | — | |
| SCHEMBL4424571 | 0.88 | — | — | |
| SCHEMBL4741407 | 0.88 | — | — | |
| SCHEMBL642580 | 0.88 | — | — | |
| SCHEMBL14400257 | 0.85 | LMNA (0.45) | — | |
| SCHEMBL15599086 | 0.85 | LMNA (0.45) | — | |
| SCHEMBL21255728 | 0.85 | LMNA (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 431 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111620348-B | Preparation method of sodium silicate for nano silicon dioxide | 安徽龙泉硅材料有限公司 | 2022-11-22 | — | — | CN | claimed |
| CN-109852326-A | A kind of polyurethane thermosol and preparation method thereof containing oxime urethane dynamic key | 东华大学 | 2019-06-07 | — | — | CN | claimed |
| EP-0398629-A2 | An oxadiazole and its salts, their use in treating dementia, their preparation and formulations | MERCK SHARP & DOHME LTD. (GB) | 1990-11-22 | — | — | EP | claimed |
| CN-122036605-A | Antagonists of GPR39 proteins | 俄勒冈健康科学大学 | 2026-05-15 | — | — | CN | disclosed |
| US-20260132147-A1 | BAX INHIBITORS AND USES THEREOF | CASE WESTERN RESERVE UNIV (US) | 2026-05-14 | — | — | US | disclosed |
| US-12479857-B2 | Bax inhibitors and uses thereof | CASE WESTERN RESERVE UNIVERSITY (US) | 2025-11-25 | — | — | US | disclosed |
| EP-4021901-B1 | SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS | BRISTOL MYERS SQUIBB CO (US) | 2025-09-24 | — | — | EP | disclosed |
| EP-4583876-A1 | COMBINATION OF A T CELL THERAPY AND CONTINUOUS OR INTERMITTENT DGK INHIBITOR DOSING | Juno Therapeutics, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| US-20250223301-A1 | KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2025-07-10 | — | — | US | disclosed |
| US-12227496-B2 | Substituted bicyclic compounds as farnesoid X receptor modulators | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-02-18 | — | — | US | disclosed |
| EP-4499640-A1 | KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF | InventisBio Co., Ltd. (CN) | 2025-02-05 | — | — | EP | disclosed |
| EP-0259621-A2 | Piperidine compounds and their preparation and use | NOVO NORDISK A/S (DK) | 1988-03-16 | — | — | EP | disclosed |
| US-4727153-A | NERVOUS SYSTEM DISORDERS | A/S FERROSAN (DK) | 1988-02-23 | — | — | US | disclosed |
| EP-0241682-A2 | Novel benzodiazepine derivatives and their preparation and use | NOVO NORDISK A/S (DK) | 1987-10-21 | — | — | EP | disclosed |
| EP-0226282-A2 | Heterocyclic compounds and their preparation and use | A/S FERROSAN (DK) | 1987-06-24 | — | — | EP | disclosed |
| EP-0225013-A1 | Heterocyclic compounds and their preparation and use | A/S FERROSAN (DK) | 1987-06-10 | — | — | EP | disclosed |
| US-4670433-A | CARDIOVASCULAR DISORDERS | A/S FERROSAN (DK) | 1987-06-02 | — | — | US | disclosed |
| EP-0220845-A1 | Heterocyclic compounds and their preparation and use | A/S FERROSAN (DK) | 1987-05-06 | — | — | EP | disclosed |
| EP-0197282-A1 | Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds | A/S FERROSAN (DK) | 1986-10-15 | — | — | EP | disclosed |
| US-3935211-A | CNS DEPRESSANT | AMERICAN CYANAMID COMPANY (US) | 1976-01-27 | — | — | US | disclosed |